Gene · 3822
Papers2,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Changes in subcutaneous white adipose tissue cellular composition and molecular programs underlie glucose intolerance in persons with HIV. | Front Immunol | 2023 | 37711619 | PubTator, text mining | PubMed |
| Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease. | Science | 2023 | 37708268 | PubTator, text mining | PubMed |
| Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection. | AIDS | 2023 | 37702421 | PubTator, text mining | PubMed |
| Mild/asymptomatic COVID-19 in unvaccinated pregnant mothers impairs neonatal immune responses. | JCI Insight | 2023 | 37698937 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis indicates fatty acid metabolism-mediated metastasis and immunosuppression in male breast cancer. | Nat Commun | 2023 | 37696831 | PubTator, text mining | PubMed |
| Secure reversal of immune evasion from refractory NSCLC and highly contagious CoV-2 mutants by using 3D-engineered multifunctional biologics. | Bioeng Transl Med | 2023 | 37693048 | PubTator, text mining | PubMed |
| mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy. | Cancers (Basel) | 2023 | 37686697 | PubTator, text mining | PubMed |
| HLA-F and LILRB1 Genetic Polymorphisms Associated with Alloimmunisation in Sickle Cell Disease. | Int J Mol Sci | 2023 | 37686397 | PubTator, text mining | PubMed |
| The Impact of Co-Infections for Human Gammaherpesvirus Infection and Associated Pathologies. | Int J Mol Sci | 2023 | 37685871 | PubTator, text mining | PubMed |
| Mycobacterium tuberculosis infection depressed cytotoxic T cells activity owing to decreasing NKG2C and increasing NKG2A expression. | Mol Immunol | 2023 | 37683324 | PubTator, text mining | PubMed |
| Harnessing the immunomodulatory effects of exercise to enhance the efficacy of monoclonal antibody therapies against B-cell haematological cancers: a narrative review. | Front Oncol | 2023 | 37681023 | PubTator, text mining | PubMed |
| Post-Acute Myocardial Infarction Heart Failure Core Genes and Relevant Signaling Pathways. | J Cardiovasc Pharmacol | 2023 | 37678296 | PubTator, text mining | PubMed |
| KLRC1 knockout overcomes HLA-E-mediated inhibition and improves NK cell antitumor activity against solid tumors. | Front Immunol | 2023 | 37675109 | PubTator, text mining | PubMed |
| Multiplex interrogation of the NK cell signalome reveals global downregulation of CD16 signaling during lentivirus infection through an IL-18/ADAM17-dependent mechanism. | PLoS Pathog | 2023 | 37669308 | PubTator, text mining | PubMed |
| Comparative transcriptomics of porcine liver-resident CD8αdim, liver CD8αhigh and circulating blood CD8αhigh NK cells reveals an intermediate phenotype of liver CD8αhigh NK cells. | Front Immunol | 2023 | 37662951 | PubTator, text mining | PubMed |
| Protocol for identifying immune checkpoint on circulating tumor cells of human pancreatic ductal adenocarcinoma by single-cell RNA sequencing. | STAR Protoc | 2023 | 37659082 | PubTator, text mining | PubMed |
| Upregulated CD8+ MAIT cell differentiation and KLRD1 gene expression after inactivated SARS-CoV-2 vaccination identified by single-cell sequencing. | Front Immunol | 2023 | 37654490 | PubTator, text mining | PubMed |
| NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells. | J Immunother Cancer | 2023 | 37648262 | PubTator, text mining | PubMed |
| High baseline frequencies of natural killer cells are associated with asymptomatic SARS-CoV-2 infection. | Curr Res Immunol | 2023 | 37645658 | PubTator, text mining | PubMed |
| Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy. | Front Immunol | 2023 | 37638058 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3822/papers?page=14